Cashman Christopher Michael 4
4 · MARINUS PHARMACEUTICALS INC · Filed Jan 30, 2019
Insider Transaction Report
Form 4
Cashman Christopher Michael
DirectorPresident and CEO
Transactions
- Sale
Common stock
2019-01-28$3.13/sh−8,142$25,484→ 239,761 total
Footnotes (1)
- [F1]Represents the sale of common stock in order to satisfy tax withholding obligations upon vesting of restricted stock.